Chapter 3002 — Customs Tariff Headings

3002.4Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products:

3002.5Cell cultures, whether or not modified:

3002.90.00Other

Calculate exact duty for your shipment Not sure about classification? Ask the Tariff Assistant

Products classified under Tariff item 30.02

Botulism Antitoxin (Trivalent, Equine)

Botulism Antitoxin (Trivalent, Equine) is an antiserum derived from equine plasma that neutralizes botulinum neurotoxins A, B, and E. It is used therapeutically to treat botulism poisoning and is presented in sterile, injectable form. This product falls under tariff item 3002.12.00 as an antiserum prepared for therapeutic uses.

Cryoprecipitated Antihemophilic Factor from Human Plasma

Cryoprecipitated Antihemophilic Factor from Human Plasma is a human plasma fraction rich in factor VIII, fibrinogen, and von Willebrand factor. It is prepared by thawing frozen plasma at 1-6°C and is used to treat hemophilia A and fibrinogen deficiencies. This product is a blood fraction prepared for therapeutic use, classified under tariff item 3002.12.00.

Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV)

Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV) is a purified immunoglobulin fraction derived from human plasma of donors with high CMV antibody titers. It is used prophylactically in transplant patients to prevent CMV infection. This product is a blood fraction prepared for therapeutic or prophylactic use, falling under tariff item 3002.12.00.

Diphtheria Antitoxin (Equine)

Diphtheria Antitoxin (Equine) is an antiserum derived from equine plasma containing antibodies to diphtheria toxin. It is used for treating severe cases of diphtheria unresponsive to antibiotics. This product is an antiserum prepared for therapeutic use, classified under tariff item 3002.12.00.

Fresh Frozen Human Plasma

Fresh Frozen Human Plasma is obtained from whole human blood and frozen within 8 hours of collection to preserve clotting factors. It is used therapeutically for patients with coagulopathies or massive transfusion needs. This product is a blood fraction prepared for therapeutic use, falling under tariff item 3002.12.00.

Hepatitis B Immune Globulin (HBIG)

Hepatitis B Immune Globulin (HBIG) is a human plasma-derived blood fraction rich in antibodies to hepatitis B surface antigen. It is used for post-exposure prophylaxis against hepatitis B. This product is an antiserum prepared for therapeutic and prophylactic applications, falling under tariff item 3002.12.00.

Human Anti-D Immunoglobulin

Human Anti-D Immunoglobulin is a blood fraction derived from human plasma containing antibodies against the D antigen on red blood cells. It is used prophylactically to prevent Rh incompatibility in pregnancies. This product is an antiserum prepared for prophylactic use, classified under tariff item 3002.12.00.

Human Immunoglobulin G (IgG) Intravenous

Human Immunoglobulin G (IgG) Intravenous (IVIG) is a pooled blood fraction from human plasma containing primarily IgG antibodies. It is used therapeutically for immune deficiencies and autoimmune disorders. This product is a blood fraction prepared for therapeutic use, falling under tariff item 3002.12.00.

Human Plasma-Derived Immunoglobulin Fraction

Human Plasma-Derived Immunoglobulin Fraction (IVIG) is a pooled human plasma fraction containing antibodies for immune deficiency treatment. It is prepared via cold ethanol fractionation and is used therapeutically. This product is a blood fraction prepared for therapeutic use, classified under tariff item 3002.12.00.

Human Plasma for Further Manufacture

Human Plasma for Further Manufacture is bulk human plasma supplied to fractionators for producing albumin, IVIG, and clotting factors. It is prepared with therapeutic end-use in mind. This product is a blood fraction prepared for therapeutic applications, falling under tariff item 3002.12.00.

Lyophilized Human Plasma for Surgical Use

Lyophilized Human Plasma for Surgical Use is dehydrated plasma reconstituted with sterile water for volume replacement in surgery. It provides essential proteins and clotting factors. This product is a blood fraction prepared for therapeutic use, classified under tariff item 3002.12.00.

Pathogen-Reduced Human Plasma

Pathogen-Reduced Human Plasma is human plasma treated with amotosalen/UVA light to inactivate viruses, bacteria, and parasites while preserving therapeutic proteins. It is used for transfusion in immunocompromised patients. This product is a modified blood fraction prepared for therapeutic use, falling under tariff item 3002.12.00.

Quarantined Human Plasma Pool

Quarantined Human Plasma Pool is pooled human plasma held in quarantine pending complete viral testing before release for fractionation. It is therapeutic source material. This product is a blood fraction prepared for therapeutic applications, classified under tariff item 3002.12.00.

Rabies Immune Globulin (Human)

Rabies Immune Globulin (Human) is a human-derived antiserum providing passive immunity against rabies virus post-exposure. It consists of purified IgG antibodies from vaccinated donors. This product is an antiserum prepared for prophylactic use, classified under tariff item 3002.12.00.

Tetanus Immune Globulin (Human)

Tetanus Immune Globulin (Human) is a human blood fraction containing high-titer antibodies against tetanus toxin. It is used for passive immunization in wound management. This product is an antiserum prepared for therapeutic and prophylactic purposes, falling under tariff item 3002.12.00.

Bulk Filgrastim

Bulk Filgrastim is a recombinant granulocyte colony-stimulating factor (G-CSF) analog that stimulates neutrophil production. It is an unmixed immunological product, not put up in measured doses or retail packings, and is classified under tariff item 3002.13.00.

Bulk Granulocyte Colony Stimulating Factor (G-CSF)

Bulk Granulocyte Colony Stimulating Factor (G-CSF) is a hematopoietin that promotes neutrophil production, directly involved in regulating immunological processes. It is supplied unmixed and not in measured doses or retail packings, fitting tariff item 3002.13.00.

Bulk Infliximab

Bulk Infliximab is a chimeric monoclonal antibody against tumor necrosis factor (TNF), used for autoimmune diseases. It is an unmixed immunological product, not put up in measured doses or retail sale, and falls under tariff item 3002.13.00.

Bulk Interferon Alpha-2a

Bulk Interferon Alpha-2a is a recombinant cytokine protein used for antiviral and anticancer treatment. It is an unmixed immunological product, not in measured doses or retail packings, and is classified under tariff item 3002.13.00.

Bulk Rituximab Monoclonal Antibody

Bulk Rituximab Monoclonal Antibody targets CD20 on B-cells for lymphoma and autoimmune treatment. It is an unmixed immunological product, not put up in measured doses or retail sale, and falls under tariff item 3002.13.00.

Pegfilgrastim Bulk

Pegfilgrastim Bulk is a pegylated form of G-CSF used to treat neutropenia. It is an unmixed immunological product, not in measured doses or retail packings, and is classified under tariff item 3002.13.00.

Recombinant Erythropoietin (EPO)

Recombinant Erythropoietin (EPO) is a glycoprotein hormone that stimulates red blood cell production and has immunological regulatory roles. It is supplied unmixed and not in measured doses or retail sale, fitting tariff item 3002.13.00.

Recombinant Human Growth Factor (HGF)

Recombinant Human Growth Factor (HGF) promotes cell growth and motility with immunological roles. It is an unmixed immunological product, not put up in measured doses or retail sale, and falls under tariff item 3002.13.00.

Recombinant Interleukin-2 (IL-2)

Recombinant Interleukin-2 (IL-2) is a growth factor protein that stimulates immune cell proliferation, used in cancer immunotherapy. It is an unmixed immunological product, not in measured doses or retail packings, and is classified under tariff item 3002.13.00.

Unmixed Adalimumab Biosimilar

Unmixed Adalimumab Biosimilar is a TNF inhibitor monoclonal antibody for rheumatoid arthritis. It is supplied unmixed in bulk, not in measured doses or retail sale, and falls under tariff item 3002.13.00.

Unmixed Cetuximab

Unmixed Cetuximab is an EGFR-targeting monoclonal antibody for cancer treatment. It is an unmixed immunological product, not put up in measured doses or retail sale, and is classified under tariff item 3002.13.00.

Unmixed Monoclonal Antibody Bevacizumab

Unmixed Monoclonal Antibody Bevacizumab is a recombinant humanized antibody that inhibits VEGF for cancer therapy. It is an unmixed immunological product, not in measured doses or retail packings, and falls under tariff item 3002.13.00.

Unmixed Omalizumab

Unmixed Omalizumab is an anti-IgE monoclonal antibody for asthma treatment. It is an unmixed immunological product, not put up in measured doses or retail sale, and is classified under tariff item 3002.13.00.

Unmixed Trastuzumab Emtansine Conjugate

Unmixed Trastuzumab Emtansine Conjugate is an antibody-drug conjugate targeting HER2 in breast cancer. It is an unmixed immunological product, not in measured doses or retail packings, and falls under tariff item 3002.13.00.

Unmixed Tumor Necrosis Factor Alpha (TNF-α)

Unmixed Tumor Necrosis Factor Alpha (TNF-α) is a cytokine involved in systemic inflammation and immune regulation. It is supplied unmixed in bulk for research and therapeutic development, not in measured doses or retail sale, and is classified under tariff item 3002.13.00.

Adalimumab Reference Product Bulk

A bulk mixed form of adalimumab monoclonal antibody for rheumatoid arthritis treatment. It is supplied for further dilution and is not in measured doses or retail packings, fitting the tariff item.

Antibody Fragment Conjugate Mixture

A mixed biotechnological preparation containing antibody fragments and conjugates used for targeted drug delivery in immunology. It is not put up in measured doses or retail packings, aligning with the tariff item's scope for mixed immunological products.

Bevacizumab Biosimilar Mixture

A bulk mixed immunological product containing bevacizumab monoclonal antibodies targeting VEGF for cancer therapy. It is not in retail form, matching the tariff item for mixed immunological products.

Biotech Antibody and Chemokine Solution

A mixed solution of monoclonal antibodies and chemokines designed for inflammation control. This product is classified under the tariff item as it is a mixed immunological product not in measured doses or retail packings.

Blended Interferon-Alpha and Interleukin-2 Preparation

A mixed solution of recombinant interferon-alpha and interleukin-2 for immunotherapy applications. It is not in measured doses or retail packings, fitting the tariff item for mixed immunological products.

Colony Stimulating Factor and Interferon Mix

A bulk blend of colony stimulating factors and interferons for immune response enhancement. This mixed product is not in retail packings, matching the tariff item's description.

Combined TNF Inhibitor and Growth Factor Serum

A bulk mixed preparation of tumor necrosis factor inhibitors and growth factors for autoimmune disease modulation. It is not in measured doses or retail packings, fitting the tariff item for mixed immunological products.

Growth Factor and MAB Blend

A bulk mixture of growth factors and monoclonal antibodies for wound healing immunology. This mixed product is not in measured doses or retail packings, aligning with the tariff item.

Hematopoietin Antibody Cocktail

A mixed hematopoietin and antibody preparation for blood disorders. It is not in measured doses or retail packings, fitting the tariff item for mixed immunological products.

Infliximab Therapeutic Mixture

A mixed immunological preparation containing infliximab monoclonal antibodies for autoimmune diseases. It is in bulk form with excipients and not in measured doses or retail packings, fitting the tariff item.

Mixed Interleukin and TNF Preparation

A combined preparation of interleukins and tumor necrosis factor modulators for rheumatoid arthritis therapy in bulk form. It is not in measured doses or retail packings, matching the tariff item.

Mixed Monoclonal Antibody Cocktail for Cancer Therapy

A blended preparation of multiple monoclonal antibodies for targeted cancer immunotherapy. This mixed product is not in measured doses or retail packings, fitting the tariff item for mixed immunological products.

Multiplex Chemokine and Hematopoietin Blend

A combined bulk solution of chemokines and hematopoietins for stem cell mobilization. It is not in measured doses or retail packings, aligning with the tariff item for mixed immunological products.

Nivolumab Immunotherapy Preparation

A mixed nivolumab monoclonal antibody product for PD-1 inhibition in cancer immunotherapy. It is in bulk form with stabilizers and not in measured doses or retail packings, aligning with the tariff item.